Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: A Meta-analysis

IMPORTANCE: Sodium-glucose cotransporter 2 (SGLT2) inhibitors favorably affect cardiovascular (CV) and kidney outcomes; however, the consistency of outcomes across the class remains uncertain. OBJECTIVE: To perform meta-analyses that assess the CV and kidney outcomes of all 4 available SGLT2 inhibit...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :JAMA Cardiol
Главные авторы: McGuire, Darren K., Shih, Weichung J., Cosentino, Francesco, Charbonnel, Bernard, Cherney, David Z. I., Dagogo-Jack, Samuel, Pratley, Richard, Greenberg, Michelle, Wang, Shuai, Huyck, Susan, Gantz, Ira, Terra, Steven G., Masiukiewicz, Urszula, Cannon, Christopher P.
Формат: Artigo
Язык:Inglês
Опубликовано: American Medical Association 2020
Предметы:
Original Investigation
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7542529/
https://ncbi.nlm.nih.gov/pubmed/33031522
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2020.4511
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы